Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Portola Pharma (PTLA)

Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,415,067
  • Shares Outstanding, K 78,484
  • Annual Sales, $ 116,640 K
  • Annual Income, $ -290,660 K
  • 60-Month Beta 2.32
  • Price/Sales 12.10
  • Price/Cash Flow N/A
  • Price/Book 19.65
Trade PTLA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.72
  • Most Recent Earnings $-0.88 on 05/11/20
  • Latest Earnings Date 08/05/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.67
  • Number of Estimates 2
  • High Estimate -0.66
  • Low Estimate -0.67
  • Prior Year -0.92
  • Growth Rate Est. (year over year) +27.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.88 +0.84%
on 06/02/20
18.07 -0.22%
on 07/01/20
+0.17 (+0.95%)
since 06/01/20
3-Month
6.10 +195.57%
on 04/16/20
18.07 -0.22%
on 07/01/20
+11.55 (+178.24%)
since 04/01/20
52-Week
5.31 +239.55%
on 03/17/20
31.73 -43.18%
on 08/09/19
-8.67 (-32.47%)
since 07/01/19

Most Recent Stories

More News
Frazier Life Sciences Adds Highly Experienced Biopharmaceutical Executive to Team

Frazier Life Sciences announced the addition of Tao Fu as a Venture Partner. He has over 25 years of business development, general management, operations, strategy, and commercial leadership experience...

PTLA : 18.03 (+0.22%)
Alexion Completes Acquisition of Portola

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the successful completion of its acquisition of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). The acquisition adds Factor Xa inhibitor reversal...

ALXN : 182.50 (+1.70%)
PTLA : 18.03 (+0.22%)
Rigrodsky & Long, P.A. Files Class Action Suit Against Portola Pharmaceuticals, Inc.

WILMINGTON, Del., June 17, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf...

PTLA : 18.03 (+0.22%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds QUMU, TCO, PTLA, and WLTW Shareholders About Its Ongoing Investigations

NEW YORK, June 05, 2020 (GLOBE NEWSWIRE) --

QUMU : 0.8988 (+0.71%)
TCO : 42.99 (unch)
PTLA : 18.03 (+0.22%)
WLTW : 231.56 (-1.19%)
KLXE, TORC, TERP, and PTLA SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., June 04, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

KLXE : 7.17 (-3.76%)
TORC : 15.96 (-3.80%)
TERP : 19.35 (-7.02%)
PTLA : 18.03 (+0.22%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MINI, WLTW, PTLA

NEW YORK, NY / ACCESSWIRE / May 22, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek...

MINI : 29.50 (-6.47%)
WLTW : 231.56 (-1.19%)
PTLA : 18.03 (+0.22%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing Investigations

NEW YORK, May 21, 2020 (GLOBE NEWSWIRE) --

STML : 11.83 (-1.42%)
PTLA : 18.03 (+0.22%)
QES : 0.9278 (-15.65%)
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - TORC, KLXE, PTLA

NEW YORK, NY / ACCESSWIRE / May 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP...

TORC : 15.96 (-3.80%)
KLXE : 7.17 (-3.76%)
PTLA : 18.03 (+0.22%)
KLXE, FSB, PTLA, and STML SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., May 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating:

KLXE : 7.17 (-3.76%)
FSB : 30.48 (-1.33%)
PTLA : 18.03 (+0.22%)
STML : 11.83 (-1.42%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA

NEW YORK, NY / ACCESSWIRE / May 16, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP...

STML : 11.83 (-1.42%)
KLXE : 7.17 (-3.76%)
PTLA : 18.03 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 18.11
1st Resistance Point 18.07
Last Price 18.03
1st Support Level 17.99
2nd Support Level 17.95
3rd Support Level N/A

See More

52-Week High 31.73
Fibonacci 61.8% 21.64
Fibonacci 50% 18.52
Last Price 18.03
Fibonacci 38.2% 15.40
52-Week Low 5.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar